E944.2 - Carbonic Acid Anhydrase Inhibitors Causing Adverse Effects In Therapeutic Use
The ICD 9 Code for Carbonic acid anhydrase inhibitors causing adverse effects in therapeutic use is listed as E944.2.
Additional information concerning this code and description can be found below including ICD 10 crosswalks / GEMS, and chapter information where available.
| ICD 9 CM Field | Value |
|---|---|
| Diagnosis Code: | E944.2 |
| Long Description: | Carbonic acid anhydrase inhibitors causing adverse effects in therapeutic use |
| Short Description: | Adv eff acetazolamide |
| Chapter: | Supplementary Classification Of External Causes Of Injury And Poisoning |
| Block: | Drugs, Medicinal And Biological Substances Causing Adverse Effects In Therapeutic Use (E930-E949) |
| ICD-9-CM Siblings (same level / similar specificity) of E944.2: | |
| E944.0 - Mercurial diuretics causing adverse effects in therapeutic use | |
| E944.1 - Purine derivative diuretics causing adverse effects in therapeutic use | |
| E944.3 - Saluretics causing adverse effects in therapeutic use | |
| E944.4 - Other diuretics causing adverse effects in therapeutic use | |
| E944.5 - Electrolytic, caloric, and water-balance agents causing adverse effects in therapeutic use | |
| E944.6 - Other mineral salts, not elsewhere classified, causing adverse effects in therapeutic use | |
| E944.7 - Uric acid metabolism drugs causing adverse effects in therapeutic use | |